| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.001 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |